DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Roncolato FT, Berton-Rigaud D, OʼConnell R. et al.
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
Gynecol Oncol 2018;
148: 36-41
doi:10.1016/j.ygyno.2017.10.019
We do not assume any responsibility for the contents of the web pages of other providers.